mRNAワクチン製造プロセス開発に最適な不純物生成を抑制した独自のRNA合成酵素のHigh Qualityグレード品を発売 タカラバイオ株式会社は、mRNAワクチン製造におけるプロセス開発に適したHigh QualityグレードのmRNA製造用酵素「PrimeCap(TM) T7 RNA Polymerase (low dsRNA), HQ ...

mRNAワクチン製造プロセス開発に適した高品質の酵素を発売 タカラバイオ株式会社は、mRNAワクチン製造におけるプロセス開発に適したHigh Quality（HQ）グレード（注1）のmRNA製造用酵素「Pyrophosphatase (inorganic),HQ」を8月31日より新発売します。 「Pyrophosphatase ...

Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...

The 3rd mRNA Process Development and Manufacturing Summit returns to Boston this September, poised to help you implement high throughput process development, scale-up mRNA synthesis and purification, ...

新型コロナウイルスワクチンの実用化で医薬メッセンジャーRNA（mRNA）が注目されています。これは、目的のタンパク質の情報を持つmRNAを人工的に合成し、投与することで病気の治療や予防をしようというものです。この医薬mRNAの品質を管理するためには ...

・調査対象となったワクチン製造業者の87%が、mRNAは将来的に重要なモダリティであると回答 ・回答者の60%以上が、需要に対応するためにmRNA製造施設の改修または新設を計画 ・新技術の導入には、熟練した人材、技術移転の専門知識、信頼性の高いサプライ ...

Enhance Speed, Purity & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indication Returning to Frankfurt, ...

LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...

Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...

In this GEN webinar, we will aim to unlock the secrets behind the iterative process development that ensures the highest standards of mRNA manufacturing. Aldevron’s process development workflow can be ...

The corona pandemic has ensured that the term "mRNA" is now also known to a large public beyond laboratories and lecture halls. However, the molecule is much more than an important component of a ...